Page: Ledipasvir/sofosbuvir product-specific bioequivalence guidance-2026/2/10

Document: Validation checklist for Type II quality variations-2026/2/10

Document: Agenda of the PRAC meeting 9-12 February 2026-2026/2/9

Page: Plasma master file certificates-2026/2/9

Document: Minutes of the COMP meeting 2-3 December 2025-2026/2/9

Document: PhV non-compliance notification contact points at National Competent Authority (NCA) level-2026/2/9

Document: PRAC recommendations on signals adopted at the 12-15 January 2026 PRAC meeting-2026/2/9

Document: New product information wording: extracts from PRAC recommendations on signals adopted at the 12-15 January 2026 PRAC-2026/2/9

Document: Concept paper on the revision of the guidelines on Good Manufacturing Practice for medicinal products - Annex 15 - Qualification and validation-2026/2/9

Document: List of signals discussed at PRAC since September 2012-2026/2/9